TriangleNCT03422198 · OUTCOME
Treatment-related Symptoms on HRQOL Using European Organization for Research and Treatment of Cancer Endometrial Cancer Module (EORTC EN24), Question 48
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- score on a scale
- Interval / dispersion
- Standard Deviation
- Time frame
- one month post-treatment
What was measured
The European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Endometrial-24 (QLQ-EN24) was used to evaluate quality of life in cancer patients with endometrial cancers. The questionnaire was given before and one month following treatment. From this assessment, one question was selected as an indicator for this outcome, which measured whether participants felt less feminine as a result of their disease or treatment. The score ranges from 0-100, with higher scores indicating feeling less feminine. Baseline scores can be found in the Baseline Characteristics module. This outcome reports the average change from baseline to Month 1.
Analysis population: Five control arm participants were excluded from analysis because they did not complete the Month 1 questionnaire. One control arm participants was excluded because they did not complete the baseline questionnaire. Three experimental arm participants were excluded from analysis because they did not complete the Month 1 questionnaire.
Groups in this outcome
Experimental: Short Course Vaginal Cuff Brachytherapy
Participants undergo short course vaginal cuff brachytherapy for 2 fractions with 1 week apart.
Control: Standard of Care Vaginal Cuff Brachytherapy
Participants undergo standard of care vaginal cuff brachytherapy for 3-5 fractions over no more than 3 weeks.
| Group | Source count |
|---|---|
| Experimental: Short Course Vaginal Cuff Brachytherapy | 51 |
| Control: Standard of Care Vaginal Cuff Brachytherapy | 48 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Experimental: Short Course Vaginal Cuff Brachytherapy | 0.65 | 22.6 | Not reported | Not reported | Not reported |
| Control: Standard of Care Vaginal Cuff Brachytherapy | -6.25 | 29.7 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 22.6
- value
- 0.65
- group Id
- OG001
- spread
- 29.7
- value
- -6.25
- denoms
- counts
- group Id
- OG000
- value
- 51
- group Id
- OG001
- value
- 48
- units
- Participants
- description
- The European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Endometrial-24 (QLQ-EN24) was used to evaluate quality of life in cancer patients with endometrial cancers. The questionnaire was given before and one month following treatment. From this assessment, one question was selected as an indicator for this outcome, which measured whether participants felt less feminine as a result of their disease or treatment. The score ranges from 0-100, with higher scores indicating feeling less feminine. Baseline scores can be found in the Baseline Characteristics module. This outcome reports the average change from baseline to Month 1.
- dispersion Type
- Standard Deviation
- groups
- description
- Participants undergo short course vaginal cuff brachytherapy for 2 fractions with 1 week apart.
- id
- OG000
- title
- Experimental: Short Course Vaginal Cuff Brachytherapy
- description
- Participants undergo standard of care vaginal cuff brachytherapy for 3-5 fractions over no more than 3 weeks.
- id
- OG001
- title
- Control: Standard of Care Vaginal Cuff Brachytherapy
- param Type
- MEAN
- population Description
- Five control arm participants were excluded from analysis because they did not complete the Month 1 questionnaire. One control arm participants was excluded because they did not complete the baseline questionnaire. Three experimental arm participants were excluded from analysis because they did not complete the Month 1 questionnaire.
- reporting Status
- POSTED
- time Frame
- one month post-treatment
- title
- Treatment-related Symptoms on HRQOL Using European Organization for Research and Treatment of Cancer Endometrial Cancer Module (EORTC EN24), Question 48
- type
- SECONDARY
- unit Of Measure
- score on a scale
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice